The AAPS Journal

, Volume 12, Issue 3, pp 243–253

Successes Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications

  • Greg Tesch
  • Shashi Amur
  • John T. Schousboe
  • Jeffrey N. Siegel
  • Lawrence J. Lesko
  • Jane P. F. Bai
Meeting Report

Abstract

Biomarkers are important tools for identifying and stratifying diseases, predicting their progression and determining the effectiveness, safety, and doses of therapeutic interventions. This is important for common chronic diseases such as diabetic nephropathy, osteoporosis, and rheumatoid arthritis which affect large numbers of patients worldwide. This article summarizes the current knowledge of established and novel biomarkers for each of these diseases as presented at the 2008 AAPS/ACCP joint symposium “Success Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications,” in Atlanta, Georgia. The advantages and disadvantages of various proteomic, metabolomic, genomic, and imaging biomarkers are discussed in relation to disease diagnosis and stratification, prognosis, drug development, and potential clinical applications. The use of biomarkers as a means to determine therapeutic interventions is also considered. In addition, we show that biomarkers may be useful for adapting therapies for individual needs by allowing the selection of patients who are most likely to respond or react adversely to a particular treatment. They may also be used to determine whether the development of a novel therapy is worth pursuing by informing crucial go/no go decisions around safety and efficacy. Indeed, regulatory bodies now suggest that effective integration of biomarkers into clinical drug development programs is likely to promote the development of novel therapeutics and more personalized medicine.

Key words

biomarkers bone diabetic nephropathy drug development genetic inflammation osteoporosis proteomics rheumatoid arthritis 

Copyright information

© American Association of Pharmaceutical Scientists 2010

Authors and Affiliations

  • Greg Tesch
    • 1
  • Shashi Amur
    • 2
  • John T. Schousboe
    • 3
    • 4
  • Jeffrey N. Siegel
    • 5
  • Lawrence J. Lesko
    • 6
  • Jane P. F. Bai
    • 6
  1. 1.Department of NephrologyMonash Medical CenterClaytonAustralia
  2. 2.Genomics groupOCP, OTS, CDER, FDASilver SpringUSA
  3. 3.Park Nicollet Health ServicesMinneapolisUSA
  4. 4.Division of Health Policy and ManagementUniversity of MinnesotaMinneapolisUSA
  5. 5.Division of Anesthesia, Analgesia and Rheumatology Products (DAARP)OND, CDER, FDASilver SpringUSA
  6. 6.OCP, OTS, CDER, FDASilver SpringUSA

Personalised recommendations